Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
HOME > BUSINESS
BUSINESS
- BMKK Applies for Add’l Indications for Taxol Based on Data in Public Domain
November 18, 2011
- Kyowa Pharm. to Buy I’rom Pharm. to Boost Sales to DPC Hospitals
November 18, 2011
- Nippon Shinyaku Grants Marketing Rights for Gaslon N･OD Tablets to Taejoon in ROK
November 18, 2011
- Meiji Seika Pharma Applies for Add’l Indications for Viccilin Based on Data in Public Domain
November 18, 2011
- Eli Lilly Japan to Provide Alimta for Free for IIT
November 18, 2011
- Fujifilm, Kyowa Kirin to Set Up Joint Venture for Biosimilars in 2012
November 17, 2011
- Takeda Initiates PII Trials of Inactivated Poliovirus, Combined 4-valent Vaccine TAD-361S in Japan
November 17, 2011
- Synix to Establish Oncology Market Research Division in December
November 17, 2011
- Zeria Aims at 50% Domestic Market Share for UC Treatment Asacol in FY2011
November 17, 2011
- High Court’s Ruling in Iressa Appeal “Extremely Fair and Reasonable”: Attorney for AZ
November 16, 2011
- Survey Finds 33% Pharmacists and Pharmacy Students Know “Established Drugs”
November 16, 2011
- Anticancer Drug SyB L-0501 Starts PII Trial for Refractory, Relapsed Multiple Myeloma (MM): SymBio
November 16, 2011
- MEDINET Initiates Clinical Study of DC Vaccine
November 16, 2011
- Japan’s Jul-Sep 2011 Ethical Drug Market Grows 7.7%: IMS Japan
November 15, 2011
- Domestic Vaccine Market Showing Strong Growth
November 15, 2011
- Sawai President to Increase “Hospital MRs” to 100
November 15, 2011
- CMIC to Develop Orphan Drugs With Partners, Funds: Chairman Nakamura
November 15, 2011
- Bayer Yakuhin Modifies Storage Conditions for Kogenate FS for Home Use
November 15, 2011
- EPS: Solid Growth in Sales, Profits Driven by SMO, CSO Businesses
November 15, 2011
- Otsuka Draws Up Strategy in Anticipation of Abilify Patent Expiration
November 14, 2011
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…